Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-04-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
独立董事对公司对外担保情况的专项说明及独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of 南微医学科技股份有限公司 regarding the company's external guarantees for the year 2021. It references regulatory requirements from the China Securities Regulatory Commission and states that no external guarantees occurred during the reporting period. The document is short (460 characters) and primarily contains a certification/opinion by independent directors rather than detailed financial data or a full report. It does not contain comprehensive financial statements or substantive financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers attestations, certifications, and special statements that do not fit other categories.
2022-04-25 Chinese
2021年度报告全文
Annual Report Classification · 100% confidence The document is titled "2021 年年度报告" which translates to "2021 Annual Report". It contains detailed financial data, management discussion and analysis, company overview, risk factors, governance, and other comprehensive information typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements, auditor's opinion, and detailed sections such as management discussion and analysis, financial data, and corporate governance. The presence of detailed quarterly data, financial metrics, and extensive narrative confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document is classified as an Annual Report (10-K equivalent). FY 2021
2022-04-25 Chinese
南微医学科技股份有限公司关于公司高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel, specifically the vice president of the company. It details the resignation, effective date, and the handover of responsibilities. There is no financial data, no mention of a report or meeting, and no regulatory certification. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2022-04-25 Chinese
南微医学科技股份有限公司关于2021年度利润分配及资本公积转增股本方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2021 annual profit distribution and capital reserve conversion to share capital plan. It details the dividend per share, capital increase by capital reserve, and the approval process including board and supervisory opinions. The document is relatively short (1700 characters) and focuses on dividend distribution and capital changes, not a full financial report. It is not an annual report or interim report but an announcement of dividend and capital changes. Therefore, it fits the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder details.
2022-04-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司关联交易之专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report on a specific related-party transaction involving the purchase of vehicles by the company from an entity related to its chairman. It includes descriptions of the transaction, pricing, necessity, impact on the company, and the approval process by the board and independent directors. It also contains the sponsor institution's verification opinion. The document is not a general financial report, earnings release, or regulatory announcement but a specialized audit or verification report on a related-party transaction. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific transactions. The document length is 3084 characters, which is sufficient for a detailed report rather than a brief announcement. Therefore, the classification is AR with high confidence. Q3 2021
2022-04-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司调整部分募投项目实施内容、拟投入募集资金金额及内部投资结构之核查意见
Regulatory Filings
2022-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.